Option chain shows key data for BIMI Holdings's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for BIMI Holdings.

BIMI Holdings (OTC:BIMI) Stock, Option Chain

BIMI Holdings

BIMI Holdings Inc is a healthcare products and services provider, offering a broad range of healthcare products and related services in the U.S. and Asia. It operates in four segments: wholesale pharmaceuticals, wholesale medical devices, medical services and retail pharmacy. The wholesale pharmaceuticals segment includes supplying prescription and OTC medicines, traditional Chinese medicines (TCM), healthcare supplies and sundry items to clinics, third party pharmacies, hospitals and other drug wholesalers. The wholesale medical devices segment distributes medical devices, including medical consumables to private clinics, hospitals, third party pharmacies and other medical device dealers. Medical services include private comprehensive hospitals operating in China.

Wall Street

Long Ideas

News

Markets

Trading Ideas

BIMI

Top 3 Health Care Stocks That Are Set To Fly This Quarter

AMD Ryzen

Movers

DALN

FFIE

FGEN

GRPN

JTAI

LMND

MGNX

NUZE

PITA

PMEC

POWL

TBIO

TIVC

Why AMD Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket

Headquarters_Rahway-Site-Entrance_HI

Intraday Update

AMKR

ATPC

BLMZ

CALC

CLDX

CNSP

CRWD

CVLT

EKSO

ENVB

FFIV

HAYW

HLIT

IMNN

INVO

ISPO

JBLU

LSCC

LUMN

MBIN

NIPG

NVAX

ONEW

PCSA

PHAR

PYPL

RGEN

RMBS

SMRT

TLRY

TRNS

TWOU

VBIV

VRNS

VSEE

Why Merck Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Tuesday&#39;s Mid-Day Session

BIMI INTL MEDICAL INC by BIMI International Medical Inc.

BIMI Holdings Inc

BIMINI CAPITAL MGMT INC A by Bimini Capital Management, Inc.

Bimini Capital Management Inc

Apple Inc.'s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) highly anticipated M4 MacBook Air could arrive ahead of schedule.
What Happened: On Monday, Bloomberg columnist Mark Gurman, who has a strong track record of predicting Apple's moves, gave an update.
He said that while the new entry-level iPads (11th generation), iPhone SE, and refreshed iPad Air models are slated for a spring release, the M4 MacBook Air is now anticipated to be available sooner.
See Also: <a href="https://www.benzinga.com/media/24/12/42640232/apple-airpods-to-get-heart-rate-temperature-sensors-and-cameras-to-help-with-ai-features-top-analyst">Apple AirPods To Get Heart Rate, Temperature Sensors, And Cameras To Help With AI Features: Top Analyst</a>
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">As I wrote in October, new entry level iPads (J481 and J482) are coming in the spring. iPhone SE, new iPad Air are on the same general timeline. The M4 MacBook Air will be earlier. <a href="https://t.co/0tUlePyFRZ">https://t.co/0tUlePyFRZ</a>
&mdash; Mark Gurman (@markgurman) <a href="https://twitter.com/markgurman/status/1871298143494795319?ref_src=twsrc%5Etfw">December 23, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Gurman had previously reported that the new M4 MacBook Air models, available in both 13-inch and 15-inch sizes, will largely resemble their 2022 predecessors. The models were expected to launch following a December software update between January and March.
The analyst had also reported that Mac Studio has been delayed slightly.
Apple did not immediately respond to <a href="https://benzinga.grsm.io/lxquj26b2sag">Benzinga's</a> request for comments.
Subscribe to the <a href="https://bztechtrends.beehiiv.com/subscribe">Benzinga Tech Trends newsletter</a> to get all the latest tech developments delivered to your inbox.
Why It Matters: In October 2024, Apple announced fiscal <a href="https://www.benzinga.com/news/earnings/24/10/41666494/apple-q4-earnings-revenue-beat-eps-beat-installed-base-hits-new-highs-iphone-sales-rise-as-apple-in">fourth-quarter revenue</a> of $94.9 billion, surpassing analyst predictions of $94.56 billion.
Mac revenue totaled $7.74 billion, slightly up from $7.61 billion in the previous year.
In the <a href="https://www.benzinga.com/news/24/04/38211401/apple-in-ai-arms-race-looks-to-revamp-lagging-mac-sales-report">fourth quarter of 2023</a>, Mac sales reflected a 34% decline from $11.5 billion in the same period the previous year. For the full year of 2023, Mac&#8217;s revenue totaled $29.4 billion, compared to $40.2 billion in 2022.
Price Action: Apple shares have risen 37.51% year-to-date. In after-hours trading, the stock dipped by 0.13%, reaching $254.95 at the time of publication, as reported by <a href="http://pro.benzinga.com/">Benzinga Pro</a>.
Photo by Isaac Martin on Unsplash
Check out more of Benzinga&#8217;s Consumer Tech coverage by <a href="https://www.benzinga.com/topic/consumer-tech">following this link</a>.&nbsp;
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/12/42495579/lawmakers-demand-apple-and-google-remove-tiktok-by-jan-19-what-you-need-to-know?itm_source=parsely-api">Apple, Google Directed To Remove TikTok From Respective App Stores By Jan 19: Here's What You Need To Know</a></li>
</ul>

Tech

Media

AAPL

New M4 MacBook Air Could Be Available Sooner Than Expected: Top Apple Analyst

Honda Motor Co. Ltd. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/HNDAF#OTC">HNDAF</a>) shares soared nearly 13.55% in Tokyo trading on Tuesday, marking their biggest one-day gain since 2008, after the Japanese automaker announced a massive share buyback plan and <a href="https://www.benzinga.com/24/12/42642773/honda-nissan-start-merger-talks">confirmed merger discussions</a> with Nissan Motor Co. Ltd. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NSANY#OTC">NSANY</a>).
While Honda shares jumped on the Tokyo exchange to 1,452 Japanese yen, Nissan stock declined marginally by 0.22% to 449 Japanese yen in Tuesday trading. U.S.-listed Honda Motor Co. Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HMC#NYSE">HMC</a>) traded higher on Monday, closing at $26.93, up 12.72% for the day. In after-hours trading, the stock rose by an additional 2.94%.
Honda plans to repurchase up to 1.1 trillion yen ($7 billion) worth of shares, representing about 24% of its outstanding stock, by December 2025. The buyback significantly exceeds its previous November plan to acquire 100 billion yen in shares.
The two Japanese auto giants confirmed they have entered formal negotiations to merge operations, which could create the world&#8217;s third-largest automaker by sales volume. 
The companies expect to conclude merger discussions by June 2025. Mitsubishi Motors Corp. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MMTOF#OTC">MMTOF</a>), Nissan&#8217;s existing strategic partner, has until January to decide whether to join the combined entity.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/12/42664887/apples-near-term-success-will-be-driven-by-strong-holiday-season-iphone-16-says-dan-ives-analyst-sees-stock-hitting-300-cupertino-hitting-4-trillion-marketcap">Apple&#8217;s Near Term Success Will Be Driven By Strong Holiday Season, iPhone 16, Says Dan Ives — Analyst Sees Stock Hitting $300, Cupertino Hitting $4 Trillion Marketcap</a></li>
</ul>
Image Via Shutterstock 
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Asia

Equities

HNDAF

MMTOF

NSANY

Honda Stock Surges Nearly 14% On Buyback, Merger Talks With Nissan

Tesla Inc.&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) robotaxi ambitions face fresh skepticism from prominent market critics, with new data from New York City&#8217;s ride-sharing market fueling debate about the technology&#8217;s revenue potential.
What Happened: GLJ Research analyst Gordon Johnson argued on social media platform X that Tesla shorts would benefit from robotaxi approval, stating the &#8220;promise is worth much, much more than the reality.&#8221; 
His comments came alongside data shared by veteran short-seller James Chanos, President and Managing Partner, Chanos and Company showing New York City&#8217;s daily ride-sharing usage averages 768,000 trips, or roughly three rides per capita monthly.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">The VERY best thing that can happen for <a href="https://twitter.com/search?q=%24TSLA&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$TSLA</a> shorts is for robotaxis to be approved, and for the economics to be come clear to all. The &quot;promise&quot; is worth MUCH, MUCH more than the &quot;reality&quot;. <a href="https://t.co/r1XUr24dRd">https://t.co/r1XUr24dRd</a>
&mdash; Gordon Johnson (@GordonJohnson19) <a href="https://twitter.com/GordonJohnson19/status/1871218869567914083?ref_src=twsrc%5Etfw">December 23, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
The skepticism contrasts sharply with bullish forecasts from leading Tesla analysts. Wedbush Securities&#8216; Dan Ives, who maintains a Street-high price target of $515, values Tesla&#8217;s autonomous business at $1 trillion and projects robotaxis could capture 20% of ride-shares by 2030.
Gary Black, Managing Partner at The Future Fund LLC, takes a more measured stance with a $380 target. Black recently questioned Tesla owners&#8217; willingness to add their vehicles to a robotaxi fleet, despite potential earnings of $40,000 annually per vehicle based on his <a href="https://www.benzinga.com/24/12/42642606/elon-musk-wants-to-raise-a-tesla-fleet-expert-estimates-vehicle-owners-can-make-40kyear-but-remains-doubtful">calculations of 25 daily trips at $1 per mile</a>.
See Also: <a href="https://www.benzinga.com/markets/equities/24/12/42664887/apples-near-term-success-will-be-driven-by-strong-holiday-season-iphone-16-says-dan-ives-analyst-sees-stock-hitting-300-cupertino-hitting-4-trillion-marketcap">Apple&#8217;s Near Term Success Will Be Driven By Strong Holiday Season, iPhone 16, Says Dan Ives — Analyst Sees Stock Hitting $300, Cupertino Hitting $4 Trillion Marketcap</a>
Why It Matters: Uber Technologies CEO Dara Khosrowshahi has also expressed doubts about Tesla&#8217;s robotaxi strategy, citing challenges in fleet management and customer service that differ <a href="https://www.benzinga.com/news/24/08/40299293/uber-ceo-dara-khosrowshahi-doubts-teslas-robotaxi-fleet-management-plans-but-maintains-hope-for-part">significantly from vehicle manufacturing</a>.
Tesla <a href="https://www.benzinga.com/markets/equities/24/12/42575664/tesla-reportedly-in-talks-with-austin">reportedly plans to launch its ride-hail service</a> in Texas and California in 2025, pending regulatory approval. The company is in early talks with Austin authorities for autonomous vehicle testing.
The electric vehicle maker&#8217;s stock has gained 71% year-to-date, with Morgan Stanley naming it their top pick for 2025. According to Benzinga Pro, Tesla currently has a <a href="https://www.benzinga.com/quote/TSLA/analyst-ratings">consensus price target</a> of $280.41 from 33 analysts, with recent ratings from Baird, Mizuho, and Goldman Sachs averaging $446.67.
<figure class="wp-block-image size-large"><img decoding="async" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/23212242/Screenshot-2024-12-24-at-7.51.57%E2%80%AFAM-1024x378.png" alt="" class="wp-image-705130" /></figure>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/24/12/42664762/after-investing-nearly-14-billion-in-openai-microsoft-reportedly-moves-to-reduce-its-dependence-on-chatgpt-parent">Microsoft Invested Nearly $14 Billion In OpenAI But Now Its Reducing Its Dependence On The ChatGPT-Parent: Report</a></li>
</ul>
Image Via Shutterstock
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Short Sellers

TSLA

Tesla Shorts, Gordon Johnson, And James Chanos Express Skepticism On Robotaxi Potential Amid Usage Data Debate: The 'Promise' Worth Much More Than Reality

Robinhood Markets Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>) CEO Vladimir Tenev said Monday that the company doesn&#8217;t rule out the prospect of holding Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) on the balance sheet for investment purposes, but there are some factors to consider.
What Happened: In an interview with Anthony Pompliano, a well-known cryptocurrency advocate, Tenev indicated that the idea came up due to the company&#8217;s growing involvement in the cryptocurrency space.
He said that the company buys cryptocurrencies for its core trading business. &#8220;We have to do the work of accounting for it, and it&#8217;s essentially on the balance sheet anyway, so there&#8217;s a real reason for it,&#8221; the CEO added.
On the question of solely holding Bitcoin for investment purposes, Tenev argued that this could possibly &#8220;complicate&#8221; things for public market investors. &#8220;You&#8217;re thinking about RobinHood as a company, generally speaking. Not like it complicates the picture to think of it as like a company, but also this quasi-Bitcoin holding play.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">I sat down with Robinhood CEO <a href="https://twitter.com/vladtenev?ref_src=twsrc%5Etfw">@vladtenev</a> to discuss the company&#39;s growth, their new crypto product, whether they will put bitcoin on their balance sheet, how financial markets are evolving, changes in regulation, and the future of the company. YouTube: <a href="https://t.co/CcvzTrI5qV">https://t.co/CcvzTrI5qV</a>… <a href="https://t.co/u79l0pE9bS">pic.twitter.com/u79l0pE9bS</a>
&mdash; Anthony Pompliano &#x1f32a; (@APompliano) <a href="https://twitter.com/APompliano/status/1871264913823350907?ref_src=twsrc%5Etfw">December 23, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Tenev emphasized that Robinhood stock is already highly correlated to Bitcoin even without the firm holding the asset on its books.
&#8220;So I would say we wouldn&#8217;t rule it out. We haven&#8217;t done it thus far but those are the kind of considerations we have,&#8221; he added.
See Also:&nbsp;<a href="https://www.benzinga.com/government/regulations/24/12/42658143/exclusive-insights-founders-of-polygon-skybridge-custodia-wonderfi-cardone-bullish-on-btc-in-2025">Exclusive Insights: Founders Of Polygon, SkyBridge, Custodia, WonderFi &amp; Cardone Bullish On BTC in 2025</a>
Why It Matters: The remarks by the CEO come amid sharp growth in the company&#8217;s cryptocurrency arm. 
Robinhood reported a twofold <a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41643195/robinhood-crypto-volumes-double-in-q3-october-number-set-to-exceed-quarterly-average-at-5b">surge in cryptocurrency volumes </a>in the third quarter. The surge in volumes helped power cryptocurrency-related revenue by 165% year-over-year.
Robinhood also held $19.45 billion worth of user cryptocurrencies as part of a safeguarding obligation.
Price Action: At the time of writing, Bitcoin was exchanging hands at $93,903.34, down 0.09% in the last 24 hours, according to <a href="https://pro.benzinga.com/dashboard?_gl=1&#x2A;380nj0&#x2A;_ga&#x2A;MTEyOTAyOTcxMy4xNzEzMzY0NTYy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDk4MzIzMi42LjEuMTcxNDk4OTE0Ni4wLjAuMA..">data from Benzinga Pro</a>.&nbsp; 
Shares of Robinhood closed 2.17% lower at $37.50 during Monday&#8217;s regular session. The stock has a consensus price target of  $38.19 based on the ratings of 16 analysts. The highest is $55, issued by Morgan Stanley on Nov. 25, and the lo<a href="https://www.benzinga.com/quote/HOOD/analyst-ratings">https://www.benzinga.com/quote/HOOD/analyst-ratings</a>w is $11, issued by Barclays on Feb. 14.
Courtesy of Robinhood Markets, Inc.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/12/42660092/microstrategy-sinks-after-nasdaq-100-inclusion-bitcoin-bet-under-fire">MicroStrategy Sinks After Nasdaq 100 Inclusion: Bitcoin Bet Under Fire?</a></li>
</ul>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

HOOD

Robinhood CEO Vlad Tenev Says Open To Holding Bitcoin For Investment Purposes But It Could 'Complicate' Things For Investors

Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) is on track to become the first company to reach a $4 trillion market capitalization by &#8220;early 2025,&#8221; driven by strong iPhone sales and artificial intelligence innovations, according to Wedbush Securities analyst Dan Ives.
What Happened: The tech giant&#8217;s shares have surged nearly 40% since January, closing at $255 per share on Monday with a market cap of $3.86 trillion. This performance puts Apple ahead of rivals NVIDIA Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) at $3.35 trillion and Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) at $3.22 trillion.
Recent supply chain checks in Asia indicate robust iPhone 16 upgrade trends heading into the Christmas season. &#8220;We believe the success of iPhone 16 with a strong holiday season ahead over the next week will be the launchpad for a renaissance of growth in Cupertino over the next 12 to 18 months,&#8221; Ives wrote in a weekend report, according <a href="https://nypost.com/2024/12/23/business/apple-poised-to-hit-4t-valuation-thanks-to-iphone-sales/">to</a> New York Post.
Apple&#8217;s recent iOS 18.2 update showcases its AI ambitions, introducing features like Visual Intelligence for text summarization and Image Playground for generating original images. These enhancements are exclusive to iPhone 15 Pro and iPhone 16 users.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://t.co/TozS00Mqgy">https://t.co/TozS00Mqgy</a> Dan Ives forecast that Apple's stock will eclipse the $300 per share plateau within the next 12 months and that the company's market capitalization will blow past $4 trillion "by early 2025." <a href="https://twitter.com/nypost?ref_src=twsrc%5Etfw">@nypost</a> &#x1f525;&#x1f3c6;&#x1f402;&#x1f37f;&#x1f384;&#x1f34f;&#x1f34e;
&mdash; Dan Ives (@DivesTech) <a href="https://twitter.com/DivesTech/status/1871277919118496164?ref_src=twsrc%5Etfw">December 23, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/12/42660092/microstrategy-sinks-after-nasdaq-100-inclusion-bitcoin-bet-under-fire">MicroStrategy Sinks After Nasdaq 100 Inclusion: Bitcoin Bet Under Fire?</a>
Why It Matters: The company&#8217;s renewed focus on AI appears to be paying off. Apple reported iPhone sales of $46.22 billion in its fiscal fourth quarter, marking a 6% year-over-year increase and reversing two consecutive quarters of decline.
Despite its strong position, Apple faces industry challenges. The company&#8217;s revenue growth of 6.07% lags behind the technology hardware sector average of 21.95%, <a href="https://www.benzinga.com/insights/news/24/12/42592861/in-depth-analysis-apple-versus-competitors-in-technology-hardware-storage-amp-peripherals-industry">according to Benzinga data</a>. However, Apple maintains superior profitability metrics, with its EBITDA of $32.5 billion significantly exceeding industry averages.
The stock&#8217;s current price-to-earnings ratio of 40.8 suggests potential undervaluation compared to industry peers, even as the company strengthens its AI capabilities through partnerships, including a recent collaboration with NVIDIA to enhance <a href="https://www.benzinga.com/24/12/42568204/nvidia-and-apple-team-up-to-supercharge-llms-with-redrafter-technique">large language model performance</a>.
Price Action: Apple stock closed at $255.27 on Monday, up 0.31% for the day. In after-hours trading, the stock edged down 0.13%. Year to date, Apple shares have surged by 37.51%, according to <a href="https://www.benzinga.com/pro/">data from Benzinga Pro</a>.
Apple has a <a href="https://www.benzinga.com/quote/AAPL/analyst-ratings">consensus price target</a> of $242.26 from 31 analysts, with a high of $300 by Wedbush and a low of $180 by DZ Bank. The most recent ratings from Morgan Stanley, Needham, and Wedbush set an average target of $277.67, implying an 8.91% upside for the stock.
<figure class="wp-block-image aligncenter size-large is-resized"><img decoding="async" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/23202742/Screenshot-2024-12-24-at-6.57.03%E2%80%AFAM-1024x376.png" alt="" class="wp-image-705096" style="width:695px;height:auto" /></figure>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/24/12/42659876/stanley-druckenmiller-pours-funds-into-1-trillion-company-already-trading-up-100">Druckenmiller Bets Big On Semiconductor Stock Just Before It Spikes To $1 Trillion</a></li>
</ul>
Image Via Shutterstock 
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

MSFT

NVDA

Apple's Near Term Success Will Be Driven By Strong Holiday Season, iPhone 16, Says Dan Ives — Analyst Sees Stock Hitting $300, Cupertino Hitting $4 Trillion Marketcap

The U.S. stock market ended in the green on Monday. The Nasdaq Composite gained over 100 points, reflecting a nearly 1% increase to 19,764.88. Meanwhile, the Dow Jones Industrial Average saw an increase of 0.2%, closing at 42,906.95. The S&amp;P 500 also experienced a rise, gaining 0.7% to reach 5,974.07.
These are the top stocks that gained the attention of retail traders and investors throughout the day:
NVIDIA Corporation
NVIDIA shares rose by 3.69%, closing at $139.67. The stock reached an intraday high of $139.79 and a low of $135.12, with a 52-week range between $47.32 and $152.89. The increase follows the Biden administration&#8217;s announcement of a&nbsp;<a href="https://www.benzinga.com/trading-ideas/movers/24/12/42660079/nvidia-shares-are-on-the-rise-today-whats-going-on">trade investigation</a>&nbsp;into China&#8217;s semiconductor industry, focusing on &#8220;legacy&#8221; semiconductors, which could result in higher U.S. tariffs.
Taiwan Semiconductor Manufacturing Company Ltd.
See Also:&nbsp;<a href="https://www.benzinga.com/markets/24/12/42638957/warren-buffetts-timeless-advice-if-youre-gonna-do-dumb-things-because-your-stock-goes-down-you-shouldnt-own-a-stock-at-all?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Warren Buffett's Timeless Advice For Investing $10,000: &#8216;If You're Gonna Do Dumb Things Because Your Stoc</a>
Taiwan Semiconductor&#8217;s stock climbed 5.15% to close at $207.36, with an intraday high of $208.05 and a low of $200.91. The 52-week range is $98.8 to $212.6. The stock&#8217;s rise is attributed to the U.S.&nbsp;<a href="https://www.benzinga.com/24/12/42661821/taiwan-semiconductor-shares-are-up-today-whats-going-on">trade probe</a>&nbsp;into China&#8217;s semiconductor policies, potentially leading to increased tariffs on Chinese components.
Advanced Micro Devices, Inc.
AMD shares increased by 4.52%, ending the day at $124.60. The stock&#8217;s intraday high was $126.34, with a low of $120.47, and a 52-week range of $117.91 to $227.30. Analysts, including Steve Frankel, have maintained a <a href="https://www.benzinga.com/24/12/42657620/amd-and-micron-top-analyst-picks-for-ai-and-next-gen-tech-growth">positive outlook</a> on AMD, citing its potential in AI and next-gen tech growth.
Rumble Inc.
Rumble&#8217;s stock surged by 81.22%, closing at $13.03, with a high of $14.63 and a low of $9.66. The 52-week range is $3.33 to $14.63. The significant rise follows Rumble&#8217;s announcement of a <a href="https://www.benzinga.com/trading-ideas/movers/24/12/42650642/rumble-stock-is-ripping-higher-monday-whats-going-on">strategic investment</a> from Tether (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">USDT</a>), amounting to $775 million.
Tesla Inc.
Tesla shares rose by 2.27%, closing at $430.60. The stock&#8217;s intraday high was $434.51, with a low of $415.41, and a 52-week range of $138.8 to $488.54. Concerns have been raised about the potential impact of the cancellation of the $7,500 <a href="https://www.benzinga.com/24/12/42641207/researcher-says-cancelation-of-7500-ev-tax-credit-could-impact-teslas-deliveries-despite-ceo-elon-musk-claiming-otherwise">EV tax credit</a> on Tesla&#8217;s U.S. deliveries.
Image via Shutterstock
Prepare for the day&#8217;s trading&nbsp;<a href="https://editorial.benzinga.com/wp-admin/Premarket%20Movers%20&amp;%20News">with top premarket movers and news</a>&nbsp;by Benzinga.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/12/42642808/americas-fatal-flaw-is-its-sharply-increasing-addiction-to-government-debt-says-expert-and-the-mother-of-all-bubbles-is-ready-to-pop?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">America&#8217;s &#8216;Fatal Flaw&#8217; Is Its &#8216;Sharply Increasing Addiction&#8217; To Government Debt, Says Expert And The &#8216;Mother Of All Bubbles&#8217; Is Ready To Pop</a></li>
</ul>
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/author/shivdeep-dhaliwal" target="_blank" rel="noreferrer noopener">Shivdeep Dhaliwal</a>

$USDT

Nvidia, Taiwan Semiconductor, AMD, Rumble, And Tesla: Why These 5 Stocks Are On Investors' Radars Today

Microsoft Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) is reportedly planning to <a href="https://www.benzinga.com/24/12/42428505/google-asks-ftc-to-kill-microsofts-monopoly-over-hosting-openai-technology-on-its-cloud-servers-report">reduce its dependence</a> on ChatGPT-maker OpenAI.
What Happened: Microsoft has been working on integrating internal and third-party artificial intelligence models into its AI product, Microsoft 365 Copilot, reported Reuters, citing sources familiar with the effort.
This move is a strategic step to diversify from the current underlying technology of OpenAI and reduce costs.
The Satya Nadella-led company is also decreasing 365 Copilot&#8217;s dependence on OpenAI due to concerns about cost and speed for enterprise users, the report noted, citing the sources.
See Also: <a href="https://www.benzinga.com/markets/24/12/42642020/steve-ballmers-bold-investment-strategy-80-of-his-portfolio-is-in-microsoft-stock-heres-why-his-keep-it-simple-approach-is-winning-big?itm_source=parsely-api">Steve Ballmer&#8217;s Winning Investment Strategy: Billionaire Says &#8216;Keep It Simple&#8217; As His Microsoft Bet Pays Off Thanks To AI Boom</a>
A Microsoft spokesperson was quoted in the report saying that OpenAI continues to be the company&#8217;s partner on frontier models. &#8220;We incorporate various models from OpenAI and Microsoft depending on the product and experience.&#8221;
OpenAI and Microsoft did not immediately respond to <a href="https://benzinga.grsm.io/lxquj26b2sag">Benzinga's</a> request for comments.
Microsoft 365 Copilot is reportedly yet to prove its return on investment to enterprises. The tech giant has not shared specific sales data on the number of licenses sold.
Subscribe to the <a href="https://bztechtrends.beehiiv.com/subscribe">Benzinga Tech Trends newsletter</a> to get all the latest tech developments delivered to your inbox.
Why It Matters: This move mirrors those of other Microsoft business units which have altered the ways they use OpenAI models. For instance, GitHub, <a href="https://www.benzinga.com/news/23/11/35623886/microsofts-github-poised-for-growth-with-ai-tools-analyst-sees-5b-arr-potential">acquired by Microsoft</a> in 2018, added models from Anthropic and Alphabet Inc.'s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) Google in October as alternatives to OpenAI's GPT-4.
Previously it was reported that company insiders were concerned about Microsoft&#8217;s AI strategy being <a href="https://www.benzinga.com/news/24/03/37605368/is-microsoft-turning-into-it-for-openai-insiders-say-tech-giants-ai-strategy-is-overly-reliant-on-ch">heavily reliant on its partnership</a> with OpenAI.
In October, the two companies engaged in talks to decide how Microsoft's $14 billion investment in OpenAI would be <a href="https://www.benzinga.com/news/24/10/41407196/openais-for-profit-structure-adds-valuation-complexity-to-microsoft-and-other-equity-investors-repor">converted into equity</a> in the AI firm.
OpenAI plans to <a href="https://www.benzinga.com/24/12/42382569/elon-musk-asks-was-it-ever-not-a-lie-as-he-accuses-openai-of-selling-out-to-microsoft-and-betraying-its-founding-mission">remove a clause that restricts</a> Microsoft&#8217;s access to its most advanced AI models upon achieving artificial general intelligence, according to a report published in December.
Price Action: Microsoft&#8217;s stock fell 0.31% on Monday, closing at $435.25. However, year-to-date, the shares have risen by 17.36%, according to <a href="https://benzinga.grsm.io/lxquj26b2sag">Benzinga Pro data</a>.
Photo via Shutterstock
Check out more of Benzinga's Consumer Tech coverage by <a href="https://www.benzinga.com/topic/consumer-tech">following this link</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/12/42633922/qualcomm-bags-win-in-chips-licensing-trial-against-arm-but-the-battle-is-not-over-yet?itm_source=parsely-api">Qualcomm Bags Win In Chips Licensing Trial Against Arm, But The Battle Is Not Over Yet</a></li>
</ul>
Disclaimer: This content was partially produced with the help of <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and was reviewed and published by Benzinga editors.

GOOG

GOOGL

Microsoft Invested Nearly $14 Billion In OpenAI But Now Its Reducing Its Dependence On The ChatGPT-Parent: Report

Bitcoin moved sideways while the altcoin market rallied significantly on Monday as traders pivoted away from the leading cryptocurrency ahead of Christmas.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Gains +/-</td>
<td>Price (Recorded at 7:45 p.m. ET)</td>
</tr>
<tr>
<td>Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)</td>
<td>-0.37%</td>
<td>$94,282.97</td>
</tr>
<tr>
<td>Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</td>
<td>+4.35%</td>
<td>$3,405.60</td>
</tr>
<tr>
<td>Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</td>
<td>+4.51%</td>
<td>$0.3227</td>
</tr>
</tbody>
</table>
</figure>
What Happened: Bitcoin remained choppy, oscillating between the $92,000-$96,000 zone. The sideways movement comes a day after the apex cryptocurrency<a href="https://www.benzinga.com/24/12/42640293/trump-congratulates-bitcoiners-on-new-all-time-highs-as-apex-crypto-suffers-first-weekly-loss-since-election-triumph"> closed at a weekly loss for the first time</a> since Donald Trump's election victory last month.
Investors shifted their capital to Ethereum and the rest of the altcoin market. The world&#8217;s largest cryptocurrency rose 4.35% to nearly $3,400.
Bitcoin's dominance fell by 1.53%, while Ethereum and altcoin saw increases in their respective market shares.
Over $278 million was liquidated from the market in the last 24 hours, with nearly equal proportions of long and short liquidations.
Bitcoin's Open Interest rose 2.49% in the last 24 hours. An increase in Open Interest, coming alongside a sideways price action, indicated a potential upside move.&nbsp;
More than 66% of traders on Binance were leveraged long on Bitcoin, according to the Long/Short Ratio.
The market remained in the "Greed" zone, according to the Cryptocurrency Fear &amp; Greed Index.
Top Gainers (24-Hours)
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Gains +/-</td>
<td>Price (Recorded at 7:45 p.m. ET)</td>
</tr>
<tr>
<td>Virtuals Protocol (VIRTUAL)</td>
<td>+29.76%</td>
<td>$2.99</td>
</tr>
<tr>
<td>Aave (AAVE)</td>
<td>+22.56%</td>
<td>$385.47</td>
</tr>
<tr>
<td>XDC Network (XDC)</td>
<td>+15.14%</td>
<td>$0.08652</td>
</tr>
</tbody>
</table>
</figure>
The global cryptocurrency market capitalization stood at $3.32 trillion, following an increase of 2.04% in the last 24 hours.
Stocks began the holiday week high on spirits. The Dow Jones Industrial Average rose 66.69 points, or 0.16%, to close at 42,906.95. The S&amp;P 500 added 0.73%, ending at 5,974.07, while the tech-heavy Nasdaq Composite spiked 0.98% to 19,764.88.
Data released Monday <a href="https://www.benzinga.com/economics/macro-economic-events/24/12/42657230/us-consumer-confidence-drops-in-december-expectations-signal-potential-economic-weakness-in-2025">indicated a sharp fall in U.S. consumer morale</a>, with the Conference Board&#8217;s Consumer Confidence Index falling to 104.7 in December, returning to mid-range levels seen during the previous two years.
The New York Stock Exchange and the Nasdaq will close early on Christmas Eve, and the markets will be shut on Christmas Day.
See More: <a href="https://www.benzinga.com/money/best-crypto-scanners">Best Cryptocurrency Scanners</a>
Analyst Notes: In a note to Benzinga, Arthur Azizov, CEO of cryptocurrency payment provider B2BINPAY attributed the market's ongoing correction to Bitcoin's growing dominance.
"Naturally, we can now anticipate a decline in Bitcoin's dominance, which should create room for altcoins to pick up momentum again," Azizov predicted. "Overall, this is all playing out as expected, with most assets returning to the 50% retracement zone of their recent impulse moves."
Widely followed cryptocurrency analyst and trader Ali Martinez drew attention to Ethereum's "most significant" support level of $3,030 &#8211; $3,130 and the "most significant" resistance level of $3,640 &#8211; $3,740.
"A sustained close outside of this no-trade zone will determine the direction of ETH&#8217;s trend," Martinez remarked.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">The most significant support level for <a href="https://twitter.com/hashtag/Ethereum?src=hash&amp;ref_src=twsrc%5Etfw">#Ethereum</a> <a href="https://twitter.com/search?q=%24ETH&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$ETH</a> is between $3,030 &#8211; $3,130, and the most significant resistance wall is $3,640 &#8211; $3,740. A sustained close outside of this no-trade zone will determine the direction of <a href="https://twitter.com/hashtag/ETH?src=hash&amp;ref_src=twsrc%5Etfw">#ETH</a>&#39;s trend. <a href="https://t.co/YCGKucGvjt">pic.twitter.com/YCGKucGvjt</a>
&mdash; Ali (@ali_charts) <a href="https://twitter.com/ali_charts/status/1871280113209266444?ref_src=twsrc%5Etfw">December 23, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Read Next:&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/12/42660092/microstrategy-sinks-after-nasdaq-100-inclusion-bitcoin-bet-under-fire">MicroStrategy Sinks After Nasdaq 100 Inclusion: Bitcoin Bet Under Fire?</a></li>
</ul>

$DOGE

$ETH

Bitcoin Flat, Ethereum, Dogecoin Spike Ahead Of Christmas: Analyst Says Decline In BTC Dominance Leaves 'Room For Altcoins To Pick Up'

On Monday, Cathie Wood-led Ark Invest executed notable trades involving Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>), Amazon.com Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), and Palantir Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>).
The Tesla Trade
Ark Invest made a significant move by selling 13,040 shares of Tesla Inc. through its ARK Innovation ETF (NYSE: ARKK). This transaction, valued at approximately $5.6 million, comes as <a href="https://www.benzinga.com/24/12/42641207/researcher-says-cancelation-of-7500-ev-tax-credit-could-impact-teslas-deliveries-despite-ceo-elon-musk-claiming-otherwise">Tesla faces potential challenges</a> related to the possible cancellation of the $7,500 EV tax credit in the U.S. Researcher Troy Teslike has highlighted that similar tax credit cancellations in Europe have previously led to a decline in Tesla&#8217;s sales. Despite these concerns, Tesla&#8217;s stock closed at $430.60, marking a 2.27% increase.
The Palantir Trade
Ark Invest sold shares of the Alex Karp-led company on Monday. Palantir, which closed at $80.69, has been actively expanding its footprint in the defense sector. Ark sold 22,807 Palantir shares through the flagship ARKK ETF. The transaction was valued at $1.84 million.
The company, alongside Anduril Industries, is leading a consortium to <a href="https://www.benzinga.com/markets/equities/24/12/42640010/palantir-and-anduril-reportedly-lead-consortium-partner-with-spacex-and-openai-to-compete-against-traditional-defense-contractors-in-850-billion-us-military-market">challenge traditional defense contractors</a>, according to a previous report. This move positions Palantir as a formidable player in the $850 billion U.S. military market.
The Amazon.com Trade
Ark Invest&#8217;s trade activity on Amazon was also noteworthy. The firm purchased 7,499 of the e-commerce giant&#8217;s shares through Ark Fintech Innovation ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKF#NYSE">ARKF</a>). The transaction was valued at nearly $1.7 million. The company&#8217;s stock, which closed at $225.06 with a slight 0.06% uptick, has been the subject of optimistic projections. An analyst with an 86% accuracy rate has predicted a 24% upside for Amazon, as detailed in a <a href="https://www.benzinga.com/analyst-ratings/price-target/24/12/42646865/this-analyst-with-86-accuracy-rate-sees-around-24-upside-in-amazon-com-here-are-5-stock-picks-for-last-week-from-wall-streets-most-accurate-analysts">recent analysis</a>. This forecast aligns with Ark&#8217;s strategic interests in high-growth potential stocks.
See Also:&nbsp;<a href="https://www.benzinga.com/markets/24/12/42638957/warren-buffetts-timeless-advice-if-youre-gonna-do-dumb-things-because-your-stock-goes-down-you-shouldnt-own-a-stock-at-all?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Warren Buffett's Timeless Advice For Investing $10,000: &#8216;If You're Gonna Do Dumb Things Because Your Stoc</a>
Other Key Trades:
<ul>
<li>Bought stock of 10X Genomics Inc. via ARKK and ARKG. </li>
<li>Bought shares of Gitlab Inc. through ARKK.</li>
</ul>
Image via Benzinga YouTube and Unsplash
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42635671/analyst-bullish-on-shiba-inu-sees-235-surge-despite-recent-fall?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Analyst Bullish on Shiba Inu, Sees 235% Surge Despite Recent Fall</a></li>
</ul>
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/author/shivdeep-dhaliwal" target="_blank" rel="noreferrer noopener">Shivdeep Dhaliwal</a>

ETFs

AMZN

ARKF

ARKK

PLTR

Cathie Wood-Led Ark Invest's Monday Moves: Dumps Tesla, Palantir Stock, Adds Amazon

GOEVW

Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending

GOEV

BNOX

CLEU

What if a pimple patch wasn't something to hide? What if it could be a fun, bold accessory? That&#8217;s precisely the concept behind Starface World, the business that turned a basic skincare item into a symbol of self-expression. Since starting in 2019, Starface has grown into a $90 million-a-year business by mixing creative ideas with strong social media skills. Here's how they did it.
<h2 class="wp-block-heading">A New Take on Acne Care</h2>
People have always tried to conceal acne, but Starface took a completely different approach. As a recent CNBC Make It video explains, founders Julie Schott and Brian Bordainick wanted to make growing up – and dealing with acne – a more positive experience. Instead of hiding blemishes, Starface's pimple patches encourage people to embrace them with pride.
Don't Miss:
<ul>
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"> you can become an investor for $0.80 per share today.</a></li>
<li>The global games market is projected to generate $272B by the end of the year —<a href="https://www.benzinga.com/money/gameflip"> for $0.55/share, this VC-backed startup with a 7M+ userbase gives investors easy access to this asset market.</a></li>
</ul>
Their first product, the yellow Hydro-Star, wasn't just a skincare tool but a fashion statement. These star-shaped patches came in bright, fun packaging and even had a mascot, Big Yellow, who &#8220;came from outer space&#8221; to help people feel better about acne. Starface soon added new colors, special ingredients and even a clear patch for people who wanted something less flashy.
Starface's success lies in its branding. Everything about the company – from its products to its messaging – is designed to <a href="https://www.benzinga.com/content/42533696/gen-z-is-redefining-brand-purpose">appeal to Gen Z</a> and Gen Alpha. The brand's playful tone, vibrant visuals and inclusive message have made it incredibly popular on social media. Platforms like Instagram and TikTok are filled with people proudly showing off their Hydro Stars.
This unique approach has created a sense of community, as owning a Starface product is about more than skincare. The company's message is that it's okay to have acne and to have fun with it.
See Also: Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Last Chance to get 4,000 of its pre-IPO shares for just $0.26/share!</a>
<h2 class="wp-block-heading">From Hype to Profits</h2>
Starface's focus on self-expression and inclusivity resonated, especially during the pandemic. The brand gained massive traction as people spent more time on Zoom and experimented with self-care. By 2023, Starface had become profitable and sold its products at major retailers like Target, Walmart and CVS.
Today, they sell patches with extra ingredients like tea tree oil and salicylic acid. They've also expanded to Canada and the UK. Despite competing with brands like Hero Cosmetics and Alba Botanica, Starface has built a strong moat around its business by focusing on fun and individuality.
<h2 class="wp-block-heading">Mixed Reviews but Lasting Impact</h2>
Not everyone loves Starface patches as an acne fix. As the CNBC video showed, some customers rave about how they help heal pimples, while others see them as a fun accessory. Either way, the brand's connection with its fans and its message of confidence make it unforgettable.
Trending: It&#8217;s no wonder Jeff Bezos holds over $70 million in art — <a href="https://www.benzinga.com/money/masterworks">this alternative asset has outpaced the S&amp;P 500 since 1995, delivering an average annual return of 11.4%. Here&#8217;s how everyday investors are getting started.</a>
The market for pimple patches is booming. According to recent research from Spherical Insights, the market valuation is expected to grow from about $500 million to nearly $1 billion by 2033. This shows how much people love these products and how brands like Starface can keep developing new ideas.
With new product launches, including a <a href="https://www.benzinga.com/insights/options/24/12/42515847/check-out-what-whales-are-doing-with-ulta">partnership with Ulta</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ULTA#NASDAQ">ULTA</a>) in 2025, Starface shows no signs of slowing down. As long as they keep innovating and staying connected to their audience, their playful and empowering approach to skincare will continue to stand out in the beauty industry.
Starface's rise reminds us of the power of unconventional thinking. Turning a basic skincare product into a lifestyle brand has shown that creativity, strong branding and social media can transform a simple idea into a thriving business.
Read Next:
<ul>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.26/share with a $1000 minimum.</a></li>
<li>If there was a new fund backed by Jeff Bezos offering a <a href="https://www.benzinga.com/money/arrived-private-credit-fund">7-9% target yield with monthly dividends would you invest in it</a>?</li>
</ul>

ULTA

Thinking Out-Of-The-Box Turned Into A $90 Million/Year Business And Showed The Power Of Strong Branding And Social Media

Ex-President Bill Clinton has been hospitalized in Washington due to a fever on Monday, according to a report.
Clinton was admitted to MedStar Georgetown University Hospital in the afternoon for tests and observation after he developed a fever. Deputy Chief of Staff for the former President, Angel Ureña, shared this news on X. The post was first <a href="https://thehill.com/policy/healthcare/5054369-bill-clinton-hospitalized-fever/">noted</a> on The Hill.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">President Clinton was admitted to MedStar Georgetown University Hospital this afternoon for testing and observation after developing a fever. He remains in good spirits and deeply appreciates the excellent care he is receiving.
&mdash; Angel Ureña (@angelurena) <a href="https://twitter.com/angelurena/status/1871326214096372135?ref_src=twsrc%5Etfw">December 23, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Ureña said, &#8220;He remains in good spirits and deeply appreciates the excellent care he is receiving.&#8221;
It is worth mentioning that Clinton was previously hospitalized for five days in 2021 due to sepsis caused by an infection, according to The Hill.
See Also: <a href="https://www.benzinga.com/24/12/42637260/elon-musk-accused-of-bullying-republicans-to-scrap-us-china-investment-safeguards-to-protect-teslas-interests?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Elon Musk Accused Of Bullying Republicans To Scrap US-China Investment Safeguards To Protect Tesla&#8217;s Interests</a>
Clinton had been <a href="https://www.benzinga.com/general/politics/24/08/40513316/bill-clinton-contrasts-harris-trump-in-fiery-dnc-speech-we-have-a-clear-choice-we-the-people-ver">actively campaigning</a> for Vice President Kamala Harris throughout the fall. Clinton had made a strong case for Harris during his speech at the Democratic National Convention (DNC).
Did You Know?
<ul>
<li>Congress Is Making Huge Investments. <a href="https://www.benzinga.com/gov-trades">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/author/shivdeep-dhaliwal" target="_blank" rel="noreferrer noopener">Shivdeep Dhaliwal</a>

Politics

General

Bill Clinton Admitted To Hospital Due To Fever In Washington

Linde (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIN#NASDAQ">LIN</a>) has outperformed the market over the past 10 years by 1.29% on an annualized basis producing an average annual return of 12.39%. Currently, Linde has a market capitalization of $201.03 billion. 
Buying $1000 In LIN: If an investor had bought $1000 of LIN stock 10 years ago, it would be worth $3,191.73 today based on a price of $421.00 for LIN at the time of writing.
<h3>Linde's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734997509_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $1000 Invested In Linde 10 Years Ago Would Be Worth Today

Agnico Eagle Mines (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AEM#NYSE">AEM</a>) has outperformed the market over the past 10 years by 1.05% on an annualized basis producing an average annual return of 12.15%. Currently, Agnico Eagle Mines has a market capitalization of $39.61 billion. 
Buying $100 In AEM: If an investor had bought $100 of AEM stock 10 years ago, it would be worth $330.84 today based on a price of $78.99 for AEM at the time of writing.
<h3>Agnico Eagle Mines's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734996621_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In Agnico Eagle Mines 10 Years Ago Would Be Worth This Much Today

Goldman Sachs Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>) has outperformed the market over the past 5 years by 6.87% on an annualized basis producing an average annual return of 19.87%. Currently, Goldman Sachs Gr has a market capitalization of $180.39 billion. 
Buying $100 In GS: If an investor had bought $100 of GS stock 5 years ago, it would be worth $246.87 today based on a price of $571.21 for GS at the time of writing.
<h3>Goldman Sachs Gr's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734994828_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $100 Invested In Goldman Sachs Gr 5 Years Ago Would Be Worth Today

WIIM

NEUE

NeueHealth shares are trading higher after the company announced it has entered into an definitive merger to be acquired for $7.33 per share.

NeueHealth, Inc. ("NeueHealth" or the "Company") (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEUE#NYSE">NEUE</a>), the value-driven healthcare company, today announced that it has entered into a definitive merger agreement pursuant to which the Company will be acquired by an affiliate of New Enterprise Associates ("NEA") at an enterprise value of approximately $1.3 billion. Upon completion of the transaction, NeueHealth will become a privately held company with the flexibility and resources to continue advancing its value-driven, consumer-centric care model.
Under the terms of the merger agreement, holders of NeueHealth common stock (other than shares that will be rolled over and certain excluded shares) will receive $7.33 per share in cash, which represents a premium of approximately 70% over the closing price of NeueHealth common stock on December 23, 2024. Certain stockholders of NeueHeath, including NEA and 12 existing NeueHealth investors (which collectively hold all of the outstanding shares of NeueHealth preferred stock), have entered into rollover agreements pursuant to which such stockholders will continue their investments by exchanging their shares of NeueHealth common stock and/or preferred stock for newly issued equity interests in the privately held company, and the Company's existing secured loan facility with Hercules Capital, Inc. will remain in place.
NeueHealth's executive leadership team will continue in their roles upon completion of the transaction and intends to roll over 100% of their equity interests for newly issued equity interests in the privately held company.

NeueHealth  Entered Into A Definitive Merger Agreement To Be Acquired By An Affiliate Of New Enterprise Associates At An Enterprise Value Of ~$1.3B, Or $7.33/Share In Cash

BIMI Holdings Inc (BIMI) stock is up 165.57% over the last 12 months. InvestorsObserverâ€&#x2122;s proprietary ranking system, gives BIMI stock a score of  23 out of a possible 100. That rank is mainly influenced by a long-term technical score of 33. BIMI's rank also includes a short-term technical score of 35.  BIMI has an Overall

Should You Sell BIMI Holdings Inc (BIMI) Stock Friday?

These Consumer Defensive stocks are trading higher:-BIMI Holdings Inc (BIMI) stock is trading at $1.87, a gain of $0.29, or 18.35%, on high volume.  Bimi Intl Medical Inc gets a Sentiment Score of Very Bearish from InvestorsObserver.  -China Jo-Jo Drugstores Inc (CJJD) stock is trading at $3.44, a rise of $0.27, or 8.52%,

Consumer Defensive Stocks Making Moves Monday: BIMI, CJJD, DDL, QSG, LFLY, HPCO, CHGG, TAL

BIMI Holdings Inc (BIMI) is near the bottom in its sector according to InvestorsObserver.BIMI gets an overall rating of 19. That means it scores higher than 19% of stocks.BIMI Holdings Inc gets a 20 rank in the Consumer Defensive sector. Consumer Defensive is number 9 out of 11 sectors. BIMI has an Overall Score of 19. Fin

Will BIMI Holdings Inc (BIMI) Stay at the Bottom of the Consumer Defensive Sector?

These Consumer Defensive stocks are trading higher:-Village Farms International Inc (VFF) stock is trading at $1.39, a gain of $0.15, or 12.1%, on high volume.  Village Farms International Inc. gets a Sentiment Score of Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price

Consumer Defensive Stocks Making Moves Monday: VFF, EAST, GOTU, LWAY, BIMI, WBA, BYND, UTI

Lexaria Bioscience, Biosig Technologies, BIMI Holdings among healthcare movers

Predictive Oncology, BIMI Holdings, IMAC Holdings among healthcare movers

BIMI receives delinquency compliance alert notice from Nasdaq

BIMI announces receipt of delinquency compliance alert notice from Nasdaq

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are a hot topic as we jump into all of the biggest news that has shares heading higher and lower on Tuesday morning!



Moving stocks this morning are earnings reports, clinical trial results and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Imunon (NASDAQ:<a href="https://investorplace.com/stock-quotes/imnn-stock-quote/">IMNN</a>) stock is rocketing more than 133% alongside <a href="https://finance.yahoo.com/news/imunon-report-topline-results-phase-200500840.html">Phase 2 clinical trial results</a>.</li>



<li>Jet AI (NASDAQ:<a href="https://investorplace.com/stock-quotes/jtai-stock-quote/">JTAI</a>) shares are soaring over 57% despite a lack of news this morning.</li>



<li>Enveric Biosciences (NASDAQ:<a href="https://investorplace.com/stock-quotes/envb-stock-quote/">ENVB</a>) stock is surging more than 32% with strong early morning trading.</li>



<li>Inspirato (NASDAQ:<a href="https://investorplace.com/stock-quotes/ispo-stock-quote/">ISPO</a>) shares are rising close to 26% without any clear news this morning.</li>



<li>Pharming (NASDAQ:<a href="https://investorplace.com/stock-quotes/phar-stock-quote/">PHAR</a>) stock is heading over 21% higher ahead of its <a href="https://www.nasdaq.com/press-release/pharming-group-report-second-quarter-and-first-half-2024-financial-results-august-1-0">upcoming earnings report</a>.</li>



<li>Sprouts Farmers Market (NASDAQ:<a href="https://investorplace.com/stock-quotes/sfm-stock-quote/">SFM</a>) shares are increasing more than 17% after <a href="https://investorplace.com/earning-results/2024/07/sfm-stock-earnings-sprouts-farmers-market-for-q2-of-2024/?utm_source=barchart&amp;utm_medium=allother">releasing its Q2 earnings</a>.</li>



<li>Harmonic (NASDAQ:<a href="https://investorplace.com/stock-quotes/hlit-stock-quote/">HLIT</a>) stock is climbing over 17% with its <a href="https://www.nasdaq.com/press-release/harmonic-announces-second-quarter-2024-results-2024-07-29">Q2 earnings report</a>.</li>



<li>Davis Commodities (NASDAQ:<a href="https://investorplace.com/stock-quotes/dtck-stock-quote/">DTCK</a>) shares are gaining more than 15% on Tuesday morning.</li>



<li>T2 Biosystems (NASDAQ:<a href="https://investorplace.com/stock-quotes/ttoo-stock-quote/">TTOO</a>) stock is getting an over 14% boost with its <a href="https://www.nasdaq.com/press-release/t2-biosystems-announces-second-quarter-2024-financial-results-2024-07-29">latest earnings report</a>.</li>



<li>Serve Robotics (NASDAQ:<a href="https://investorplace.com/stock-quotes/serv-stock-quote/">SERV</a>) shares are up more than 14% after announcing <a href="https://www.nasdaq.com/press-release/investor-one-one-meeting-requests-open-29th-annual-enercom-denver-energy-investment">investor meeting plans</a>.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>QXO (NASDAQ:<a href="https://investorplace.com/stock-quotes/qxo-stock-quote/">QXO</a>) stock is crashing over 80% after <a href="https://finance.yahoo.com/news/high-flying-qxo-erases-36-221350996.html">announcing a private placement</a>.</li>



<li>BIMI (NASDAQ:<a href="https://investorplace.com/stock-quotes/bimi-stock-quote/">BIMI</a>) shares are plummeting more than 23% on Tuesday morning.</li>



<li>Ekso Bionics (NASDAQ:<a href="https://investorplace.com/stock-quotes/ekso-stock-quote/">EKSO</a>) stock is diving over 22% alongside its <a href="https://finance.yahoo.com/news/ekso-bionics-ekso-reports-q2-214505963.html">Q2 earnings results</a>.</li>



<li>Symbotic (NASDAQ:<a href="https://investorplace.com/stock-quotes/sym-stock-quote/">SYM</a>) shares are tumbling more than 18% after <a href="https://finance.yahoo.com/news/symbotic-inc-sym-reports-q3-213008077.html">reporting a Q3 loss</a>.</li>



<li>Lattice Semiconductor (NASDAQ:<a href="https://investorplace.com/stock-quotes/lscc-stock-quote/">LSCC</a>) stock is taking an almost 18% beating with its <a href="https://seekingalpha.com/article/4707817-lattice-semiconductor-corporation-lscc-q2-2024-earnings-call-transcript?source=feed_all_articles">latest earnings report</a>.</li>



<li>Lipella Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/lipo-stock-quote/">LIPO</a>) shares are falling over 17% <a href="https://investorplace.com/2024/07/why-is-lipella-pharmaceuticals-lipo-stock-up-149-today/">after a rally yesterday</a>.</li>



<li>Cognition Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/cgtx-stock-quote/">CGTX</a>) stock is dropping more than 16% as it continues downward movement <a href="https://investorplace.com/2024/07/why-is-cognition-therapeutics-cgtx-stock-down-33-today/">on study results</a>.</li>



<li>NLS Pharmaceutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/nlsp-stock-quote/">NLSP</a>) shares are sliding over 14% <a href="https://investorplace.com/2024/07/why-is-nls-pharmaceutics-nlsp-stock-up-48-today/">following a merger rally yesterday</a>.</li>



<li>Troops (NASDAQ:<a href="https://investorplace.com/stock-quotes/troo-stock-quote/">TROO</a>) stock is decreasing more than 13% today.</li>



<li>Loop Media (NYSEMKT:<a href="https://investorplace.com/stock-quotes/lptv-stock-quote/">LPTV</a>) shares close out our pre-market stock movers down over 12% after <a href="https://www.stocktitan.net/news/LPTV/loop-media-inc-announces-new-partnership-and-nationwide-launch-of-u3mffuxudp5v.html">jumping yesterday on a new partnership</a>.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/2024/07/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-tuesday-july-30th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
It&rsquo;s time to dive into the biggest pre-market stock movers for Wednesday as we check out all of the hottest news happening this morning!



Moving stocks this morning are clinical trial updates, earnings reports and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Primech (NASDAQ:<a href="https://investorplace.com/stock-quotes/pmec-stock-quote/">PMEC</a>) stock is rocketing close to 90% alongside heavy pre-market trading.</li>



<li>Nuzee (NASDAQ:<a href="https://investorplace.com/stock-quotes/nuze-stock-quote/">NUZE</a>) shares are soaring more than 69% with strong early morning trading.</li>



<li>Heramba Electric (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PITA#NASDAQ">PITA</a>) stock is surging over 43% with increasing trading activity this morning.</li>



<li>Bionomics (NASDAQ:<a href="https://investorplace.com/stock-quotes/bnox-stock-quote/">BNOX</a>) shares are gaining more than 31% on a <a href="https://www.nasdaq.com/press-release/bionomics-announces-successful-end-phase-2-meeting-fda-development-bnc210-post">Phase 2 clinical trial meeting</a>.</li>



<li>Powell Industries (NASDAQ:<a href="https://investorplace.com/stock-quotes/powl-stock-quote/">POWL</a>) stock is rising over 25% after <a href="https://finance.yahoo.com/news/powell-industries-powl-q3-earnings-214005995.html">beating Q3 estimates</a>.</li>



<li>BIMI International Medical (NASDAQ:<a href="https://investorplace.com/stock-quotes/bimi-stock-quote/">BIMI</a>) shares are increasing more than 20% with strong early morning trading today.</li>



<li>DallasNews (NASDAQ:<a href="https://investorplace.com/stock-quotes/daln-stock-quote/">DALN</a>) stock is climbing over 18% with its <a href="https://investorplace.com/earning-results/2024/07/daln-stock-earnings-dallasnews-for-q2-of-2024/">Q2 earnings report</a>.</li>



<li>Faraday Future (NASDAQ:<a href="https://investorplace.com/stock-quotes/ffie-stock-quote/">FFIE</a>) shares are jumping more than 17% after <a href="https://finance.yahoo.com/news/faraday-future-regains-compliance-nasdaq-031500213.html">regaining listing compliance</a>.</li>



<li>GraniteShares 2x Long AMD Daily ETF (NASDAQ:<a href="https://investorplace.com/stock-quotes/amdl-stock-quote/">AMDL</a>) stock is getting an over 17% boost this morning.</li>



<li>Talen Energy (NASDAQ:<a href="https://investorplace.com/stock-quotes/tln-stock-quote/">TLN</a>) shares are up more than 17% after <a href="https://www.nasdaq.com/press-release/talen-reports-pjm-auction-results-2025-2026-planning-year-2024-07-30">reporting PJM Auction Results</a>.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>FibroGen (NASDAQ:<a href="https://investorplace.com/stock-quotes/fgen-stock-quote/">FGEN</a>) stock is plummeting over 44% on a <a href="https://www.nasdaq.com/press-release/fibrogen-announces-topline-results-two-late-stage-pamrevlumab-pancreatic-cancer">failed clinical trial</a>.</li>



<li>Macrogenics (NASDAQ:<a href="https://investorplace.com/stock-quotes/mgnx-stock-quote/">MGNX</a>) shares are diving more than 26% as it <a href="https://www.nasdaq.com/press-release/macrogenics-provides-vobramitamab-duocarmazine-update-2024-07-30">discontinues a clinical trial</a>.</li>



<li>Jet AI (NASDAQ:<a href="https://investorplace.com/stock-quotes/jtai-stock-quote/">JTAI</a>) stock is tumbling over 21% on an <a href="https://www.nasdaq.com/press-release/jetai-announces-expiration-and-successful-results-exchange-offer-and-consent">exchange offer for its warrants</a>.</li>



<li>Penumbra (NYSE:<a href="https://investorplace.com/stock-quotes/pen-stock-quote/">PEN</a>) shares are taking a more than 18% beating <a href="https://finance.yahoo.com/news/penumbra-pen-reports-q2-earnings-230019255.html">with its Q2 earnings report</a>.</li>



<li>Groupon (NASDAQ:<a href="https://investorplace.com/stock-quotes/grpn-stock-quote/">GRPN</a>) stock is sliding over 17% <a href="https://investorplace.com/earning-results/2024/07/grpn-stock-earnings-groupon-for-q2-of-2024/">on an EPS miss</a>.</li>



<li>Definitive Healthcare (NASDAQ:<a href="https://investorplace.com/stock-quotes/dh-stock-quote/">DH</a>) shares are falling more than 16% without any clear news this morning.</li>



<li>Netcapital (NASDAQ:<a href="https://investorplace.com/stock-quotes/ncpl-stock-quote/">NCPL</a>) stock is dropping over 16% after <a href="https://investorplace.com/earning-results/2024/07/ncpl-stock-earnings-netcapital-for-q4-of-2024/">missing estimates in fiscal 2024</a>.</li>



<li>O-I Glass (NYSE:<a href="https://investorplace.com/stock-quotes/oi-stock-quote/">OI</a>) shares are decreasing more than 15% <a href="https://www.stocktitan.net/news/OI/o-i-glass-reports-second-quarter-2024-71rm58wp8yg0.html">with its Q2 results</a>.</li>



<li>Lemonade (NYSE:<a href="https://investorplace.com/stock-quotes/lmnd-stock-quote/">LMND</a>) stock is slipping over 13% <a href="https://www.marketwatch.com/story/lemonades-stock-slides-14-after-posting-q2-loss-5e14bea8">alongside a weak guidance</a>.</li>



<li>Tivic Health Systems (NASDAQ:<a href="https://investorplace.com/stock-quotes/tivc-stock-quote/">TIVC</a>) shares close out our pre-market stock movers down 13% <a href="https://investorplace.com/2024/07/tivic-health-systems-tivc-stock-pops-another-39-july-29th/">after a rally yesterday</a>.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/2024/07/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-wednesday-july-31st/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Comments

BIMI Holdings

BIMI Holdings (BIMI) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga